Javascript must be enabled to continue!
The effect of antipyretic medication on the relationship between heart rate, respiratory rate and temperature in acutely admitted medical patients: A retrospective study
View through CrossRef
Research has shown an association between body temperature, heart rate and respiratory rate. We speculated that antipyretics could influence this. We performed this study with the aim of clarifying the association.
We included 1,612 acutely admitted medically ill patients and registered their use of antipyretics. We performed crude and adjusted linear regression analyses. In adjusted analysis, we found that heart rate increased with 7.3 (95% CI: 4.5, 10.1) beats/min/℃ in patients who were not on antipyretics and 10.0 (95% CI: 6.2, 13.9) beats/min/℃ in patients who were.
Respiratory rate increased 0.4 (95% CI: -0.2, 0.9) and 1.5 (95% CI: 0.6, 2.3), respectively. Our data shows that use of antipyretics affect the association between temperature, heart rate and respiratory rate positively.
Rila Publications Ltd
Title: The effect of antipyretic medication on the relationship between heart rate, respiratory rate and temperature in acutely admitted medical patients: A retrospective study
Description:
Research has shown an association between body temperature, heart rate and respiratory rate.
We speculated that antipyretics could influence this.
We performed this study with the aim of clarifying the association.
We included 1,612 acutely admitted medically ill patients and registered their use of antipyretics.
We performed crude and adjusted linear regression analyses.
In adjusted analysis, we found that heart rate increased with 7.
3 (95% CI: 4.
5, 10.
1) beats/min/℃ in patients who were not on antipyretics and 10.
0 (95% CI: 6.
2, 13.
9) beats/min/℃ in patients who were.
Respiratory rate increased 0.
4 (95% CI: -0.
2, 0.
9) and 1.
5 (95% CI: 0.
6, 2.
3), respectively.
Our data shows that use of antipyretics affect the association between temperature, heart rate and respiratory rate positively.
Related Results
NICU Medication Errors: Describing the Cause and Nature of Medication Errors in a NICU in Qatar
NICU Medication Errors: Describing the Cause and Nature of Medication Errors in a NICU in Qatar
IntroductionA medication error can be defined as “any error occurring in the medication use process” and focuses on problems with the delivery of medication to a patient [1]. Medic...
Medication beliefs and adherence– exploring pharmaceutical care interventions and patients’ experiences
Medication beliefs and adherence– exploring pharmaceutical care interventions and patients’ experiences
<strong>Background</strong>
In pharmaceutical care, healthcare professionals collaborate with patients to optimise medication therapy. For patients usin...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Abstract 2233: Biobehavioral Factors and Heart Failure Medication Adherence
Abstract 2233: Biobehavioral Factors and Heart Failure Medication Adherence
Background:
Medication adherence in heart failure (HF) patients reduces hospitalizations and improves outcomes, yet it is variable. This study evaluated adherence rates...
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Abstract
Introduction: Pilonidal sinus disease is increasingly recognized in the pediatric population, yet evidence on its clinical characteristics and surgical outcomes in childre...
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
1
Jose F.
Tellez‐Zenteno,
1
Scott B.
Patten, and
1
Samuel
Wiebe
...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...

